NooThera Technologies, LLC

Using patent pending technology we stop Alzheimer's degeneration, start neuronal growth, and retune the brain, in humans, with a non-invasive device.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Estero, FL, USA
  • Currency USD
  • Founded May 2015
  • Employees 6
  • Website noothera.com

Company Summary

We have evidence in double blind, placebo controlled trials that low level light therapy (LLLT) can stop the degeneration of Alzheimer's and regrow neurons, in situ. This is well covered by the scientific literature and ignored by industry.

We found that neurofeedback using LORETA Z Score QEEG therapy can then improve cognition.

Video overview can be viewed here: https://www.youtube.com/watch?v=uodo4pMxJZo&feature=youtu.be

Team

  • Michael L. Weiner
    CEO & Co-Founder

    www.lifeboat.com/ex/bios.michael.l.weiner

  • Stuart G. MacDonald
    VP R&D

    Stu joined us in 2001, and headed R&D for our pacemaker spin-off, Biophan. Stu managed a Collaborative Research and Development Agreement with the FDA on safety issues. Stu joined us from J&J, where he was VP of Instrumentation R&D for a $1+ billion division, managing a 400 person organization.

  • Michael Weiner

Advisors

  • Todd Tidgewell, Nixon Peabody
    Lawyer
    Unconfirmed
    Keith Ellison
    Accountant
    Unconfirmed

Previous Investors

  • Boston Scientific in previous venture
    Unconfirmed
    Patent Ventures, LLC in previous venture
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free